Centessa Pharmaceuticals (CNTA) PT Raised to $5 at Goldman Sachs
Tweet
Share
E-mailGet Alerts CNTA Hot Sheet
Price: $40.50 --0%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Goldman Sachs analyst Andrea Tan raised the price target on Centessa Pharmaceuticals (NASDAQ: CNTA) to $5.00 (from $4.50) while maintaining a Neutral rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- Lenovo Group Ltd. (992:HK) (LNVGY) PT Raised to HK$45 at Nomura/Instinet
- Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,278 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
